Children and Adults with Refractory Acute Graft-versus-Host Disease Respond to Treatment with the Mesenchymal Stromal Cell Preparation “MSC-FFM”—Outcome Report of 92 Patients

Application of “primed” Mesenchymal Stromal Cells in hematopoietic stem cell transplantation: Current status and Future prospects

(2019) Vaijayanti Prakash Kale   STEM CELLS AND DEVELOPMENT

Manufacturing mesenchymal stromal cells for the treatment of graft-versus-host disease: a survey amongst centers affiliated to the European Group of Blood and Marrow Transplantation

(2018) Cristina Trento et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Effective treatment of steroid and therapy-refractory acute graft-versus-host disease with a novel mesenchymal stromal cell product (MSC-FFM)

(2018) Peter Bader et al.   BONE MARROW TRANSPLANTATION

Patterns of infection and infection-related mortality in patients with steroid-refractory acute graft versus host disease

(2016) I García-Cadenas et al.   BONE MARROW TRANSPLANTATION

Good responses but high TRM in adult patients after MSC therapy for GvHD

(2016) U Salmenniemi et al.   BONE MARROW TRANSPLANTATION

Mesenchymal stromal cells from pooled mononuclear cells of multiple bone marrow donors as rescue therapy in pediatric severe steroid-refractory graft-versus-host disease: a multicenter survey

(2016) Z. Kuci et al.   HAEMATOLOGICA

Mesenchymal stromal cells from pooled mononuclear cells of multiple bone marrow donors as rescue therapy in pediatric severe steroid-refractory graft-versus-host disease: a multicenter survey

(2016) Z. Kuci et al.   HAEMATOLOGICA

Survival after mesenchymal stromal cell therapy in steroid-refractory acute graft-versus-host disease: systematic review and meta-analysis

(2016) Shahrukh Hashmi et al.   Lancet Haematology

Biomarker profiling of steroid-resistant acute GVHD in patients after infusion of mesenchymal stromal cells

(2015) L C J te Boome et al.   LEUKEMIA

Mesenchymal Stromal Cells for Treatment of Acute Steroid-Refractory Graft Versus Host Disease: Clinical Responses and Long-Term Outcome

(2015) Felix von Dalowski et al.   STEM CELLS

Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric Patients

(2013) Martino Introna et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

First- and Second-Line Systemic Treatment of Acute Graft-versus-Host Disease: Recommendations of the American Society of Blood and Marrow Transplantation

(2012) Paul J. Martin et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Donor selection and release criteria of cellular therapy products

(2012) H. Eichler et al.   VOX SANGUINIS

Long-Term Complications, Immunologic Effects, and Role of Passage for Outcome in Mesenchymal Stromal Cell Therapy

(2011) Lena von Bahr et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Steroid-refractory GVHD: T-cell attack within a vulnerable endothelial system

(2011) T. Luft et al.   BLOOD

Mesenchymal Stromal Cells Engage Complement and Complement Receptor Bearing Innate Effector Cells to Modulate Immune Responses

(2011) Guido Moll et al.   PLoS One

Platelet-lysate-Expanded Mesenchymal Stromal Cells as a Salvage Therapy for Severe Resistant Graft-versus-Host Disease in a Pediatric Population

(2010) Giovanna Lucchini et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Efficacy and Safety of Ex Vivo Cultured Adult Human Mesenchymal Stem Cells (Prochymal™) in Pediatric Patients with Severe Refractory Acute Graft-Versus-Host Disease in a Compassionate Use Study

(2010) Vinod K. Prasad et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium

(2008) M von Bonin et al.   BONE MARROW TRANSPLANTATION

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

(2008) Katarina Le Blanc et al.   LANCET

Current and future approaches for control of graft-versus-host disease

(2008) John Koreth et al.   Expert Review of Hematology